U.S. Stock News

If you are wondering whether Texas Roadhouse at around US$160.99 still offers value, the next sections will walk through what the current share price might be implying about the business. Over the last week the stock return is 0.3%, the 30 day return is a 2.5% decline and year to date the return is a 6.1% decline, while the 3 year and 5 year returns sit at 51.0% and 70.5% respectively. Recent headlines have kept Texas Roadhouse in focus, with ongoing attention on the broader restaurant...

In April 2026, StandardAero announced a long-term agreement with Rolls-Royce to provide repair and overhaul support from its Maryville, Tennessee facility for the MT7 marine gas turbine engine powering the U.S. Navy’s Ship to Shore Connector program, leveraging the MT7’s 90% common architecture with the AE 1107C. This deal deepens StandardAero’s role in defense-focused maintenance services and builds on its existing authorization to support several Rolls-Royce military engine platforms,...

AerCap Holdings N.V. ( NYSE:AER ) defied analyst predictions to release its first-quarter results, which were ahead of...

Cisco Systems (NasdaqGS:CSCO) reports reaching its 2025 Scope 1 and Scope 2 greenhouse gas emissions target ahead of schedule. The company now matches 100% of its global electricity demand with renewable sources at owned and leased sites. Progress comes alongside new initiatives in building electrification, AI driven energy optimization, and expansion of its electric vehicle fleet. These steps mark concrete movement toward Cisco’s 2040 net zero emissions goal. Cisco, best known for its...

For readers wondering whether US Foods Holding is still reasonably priced after its recent run, or if the easy money has already been made, this article walks through what the current share price might be implying about value. At a last close of US$93.49, the stock has delivered returns of 0.7% over 7 days, 1.4% over 30 days, 25.3% year to date, 40.9% over 1 year and 133.0% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent...

In the first quarter of 2026, Virtu Financial reported revenue of US$1.10 billion and net income of US$182.31 million, with basic earnings per share from continuing operations of US$1.99, and maintained a quarterly dividend of US$0.24 per share payable on June 15, 2026. The quarter marked Virtu’s highest-ever adjusted net trading income, supported by over US$500 million of additional trading capital and strong contributions from both its Market Making and Execution Services segments. We’ll...

Investors may be wondering whether Millicom International Cellular at about US$84.88 is still offering value after a strong run, or if most of the easy gains are already behind it. The stock has recent returns of 0.8% over 7 days, 13.3% over 30 days, 50.1% year to date and 177.5% over 1 year, with a very large 3-year gain and a more than 2x 5-year gain that can all influence how you think about risk and reward today. Recent coverage around Millicom International Cellular has focused on its...

In the first quarter of 2026, Verizon Communications reported revenue of US$34,440 million and net income of US$5,045 million, with basic and diluted EPS from continuing operations of US$1.20, all modestly higher than a year earlier. The company coupled this earnings beat and guidance raise with its first positive first-quarter postpaid phone net additions since 2013 and highlighted AI-focused partnerships and operational improvements under new CEO Dan Schulman. We’ll now examine how...

If you are wondering whether Centessa Pharmaceuticals at around US$39.42 is still offering value after its surge, you are asking the right question for this stock. The share price has delivered a 66.4% return year to date and 192.0% over the last year, with the 3 year return described as very large, even though the last 30 days have seen a small 0.8% decline and the last week has been flat at 0.0%. Recent coverage has focused on Centessa Pharmaceuticals as a higher growth biotech name, and...

If you are wondering whether KeyCorp's current share price offers value, it helps to step back and look at what the market has been pricing in recently. The stock last closed at US$22.11, with returns of 0.5% over 7 days, 10.3% over 30 days, 5.4% year to date, 54.2% over 1 year and 22.9% over 5 years. This gives you a sense of how sentiment has shifted over different time frames. Recent headlines around KeyCorp have focused on the broader banking sector's funding costs, regulatory scrutiny...

If you are wondering whether Under Armour at US$6.29 is attractively priced or still a value trap, the starting point is understanding what the current market price actually implies about the business. The stock has returned 6.4% over the last 30 days and 18.9% year to date, while the 1 year return sits at 8.4% against a much weaker 3 year and 5 year record of 24.1% and 74.5% declines. Recent headlines have focused on how Under Armour is repositioning its brand and product lineup to stay...

In April 2026, MarketAxess Holdings filed a definitive proxy statement urging shareholders to vote against John Chevedden’s proposal to allow investors holding 10% of outstanding stock to call special shareholder meetings, while also reshuffling board committee assignments effective May 1, 2026. This governance clash over special meeting rights highlights tensions between management control and shareholder influence at a time when analysts are increasingly optimistic about MarketAxess’s...

If you are wondering whether JetBlue Airways at around US$4.66 offers value or just more volatility, the key is to understand what the current price actually reflects about the business. The stock has had a mixed run, with an 11.3% decline over the last 7 days, a 5.3% gain over 30 days, year to date returns of 1.4%, and a 6.3% return over the past year, sitting against much weaker 3 and 5 year results of 31.5% and 75.9% declines. These swings have come alongside ongoing headlines about the...

Recent share performance and what it means for Zoetis investors Zoetis (ZTS) has drawn fresh attention after a challenging run for the stock, with the share price showing negative returns over the past month, past 3 months, year to date, and over the past year. For investors following the animal health group, this weak price performance contrasts with a business that reported US$9.47b in revenue and US$2.67b in net income, supported by mid single digit annual growth in both measures. See our...

XP Inc. (NasdaqGS:XP) released its audited 2025 annual results, giving investors a detailed view of the company’s most recent financial year. The company announced a new cash dividend, signaling a direct return of capital to shareholders. XP also launched a fresh share repurchase program and reported significant ownership positions held by institutional investors. XP operates as a financial services platform, connecting retail and institutional clients to investment products and advisory...

Why AppFolio (APPF) Is Back on Investors' Radar AppFolio (APPF) has drawn fresh attention after its first quarter update, which paired new earnings figures with higher full year revenue guidance and a leadership move in product management. For the quarter ended March 31, 2026, AppFolio reported sales of US$262.21 million compared with US$217.7 million a year earlier. Net income was US$42.42 million compared with US$31.38 million, with basic earnings per share from continuing operations at...

Shareholders of Generac Holdings Inc. ( NYSE:GNRC ) will be pleased this week, given that the stock price is up 19% to...

This article considers whether NIQ Global Intelligence, at around US$10.93, offers value or simply appears cheap on the surface by examining what the current price might really imply. The share price has eased back recently, with a 7‑day return of a 2.6% decline, a 30‑day return of a 3.9% decline, and a year‑to‑date return of a 30.7% decline. Recent coverage has focused on the stock's weaker near‑term returns and what they might signal about investor expectations, which helps explain why...

Viavi Solutions (VIAV) just posted Q3 2026 results with revenue of US$406.8 million and basic EPS of US$0.03, while on a trailing twelve month basis revenue stands at US$1.4 billion with a basic EPS loss of US$0.24. Over recent quarters, the company has seen revenue move from US$270.8 million in Q2 2025 to US$406.8 million in Q3 2026, alongside basic EPS shifting from US$0.04 in Q2 2025 to US$0.03 in the latest quarter and swinging between profits and losses in the periods in between. This...

ATI (ATI) has opened Q1 2026 earnings season with Q4 2025 revenue of US$1.2 billion and basic EPS of US$0.71, setting the stage against a current share price of US$155.46 as investors focus on how these results fit into the company’s recent earnings trajectory. Over the past year, quarterly revenue has ranged from US$1.1 billion to US$1.2 billion, while basic EPS has moved between US$0.64 and US$0.80. This provides a clear view of how the top and bottom line have tracked together across...

FTI Consulting (FCN) has opened 2026 with investors focused on how its latest quarter measures up to a steady run of results that most recently saw Q4 2025 revenue of US$990.7 million and basic EPS of US$1.80, supported by trailing 12 month basic EPS of US$8.33 on revenue of about US$3.8 billion. Over the past few quarters the company has seen revenue move from US$894.9 million in Q4 2024 to US$898.3 million in Q1 2025 and then to US$990.7 million in Q4 2025, while basic EPS has ranged from...

Investors may be wondering if Celanese is still attractively priced after its recent run, or if most of the value story is already reflected in the share price. The stock last closed at US$67.76, with returns of 3.9% over the past week, 3.0% over the past month, 60.7% year to date, and 49.6% over the past year, set against longer term returns of negative 30.6% over three years and negative 56.5% over five years. Recent coverage has focused on Celanese's position in the chemicals sector and...

Bio-Rad Laboratories (NYSE:BIO) issued a cautious revenue outlook for 2026. The company highlighted a material revenue impact tied to ongoing geopolitical disruptions in the Middle East. Management reported progress on the Stilla acquisition, which is expected to be accretive within the year, and outlined business efficiency measures. Bio-Rad enters this update with a mixed track record, with the share price at $280.12 and a 1 year return of 16.5% but a 3 year return of 39.4% and a 5 year...

How ExlService Holdings’ Recent Performance Sets the Stage for Investors ExlService Holdings (EXLS) has drawn fresh investor attention after a mixed stretch in its share performance, with a modest gain over the past month contrasting with weaker returns over the past 3 months and year to date. See our latest analysis for ExlService Holdings. That recent 4.7% 30 day share price return comes after a much weaker 90 day share price return of 18.6% and a 1 year total shareholder return of 31.2%...